Long term use of desmopressin for urinary symptoms in multiple sclerosis.

Abstract

The benefit of desmopressin (DDAVP) in the treatment of the urinary symptoms of multiple sclerosis has until now only been shown in short crossover studies of up to 6 weeks. We report 19 patients who have used the drug for an average of 2 years and 4 months, 18 of whom confirmed continued dramatic benefit without any obvious change in dosage used or… (More)

Topics

Cite this paper

@article{Tubridy1999LongTU, title={Long term use of desmopressin for urinary symptoms in multiple sclerosis.}, author={Niall Tubridy and Russell S Addison and Frederick Schon}, journal={Multiple sclerosis}, year={1999}, volume={5 6}, pages={416-7} }